Literature DB >> 18708633

Role of P63 (CKAP4) in binding of surfactant protein-A to type II pneumocytes.

Sandra R Bates1, Altaf S Kazi, Jian-Qin Tao, Kevin J Yu, Daniel S Gonder, Sheldon I Feinstein, Aron B Fisher.   

Abstract

We have recently described a putative receptor for lung surfactant protein-A (SP-A) on rat type II pneumocytes. The receptor, P63, is a 63-kDa type II transmembrane protein. Coincubation of type II cells with P63 antibody (Ab) reversed the inhibitory effect of SP-A on secretagogue-stimulated surfactant secretion from type II cells. To further characterize SP-A interactions with P63, we expressed recombinant P63 protein in Escherichia coli and generated antibodies to P63. Immunogold electron microscopy confirmed endoplasmic reticulum and plasma membrane localization of P63 in type II cells with prominent labeling of microvilli. Binding characteristics of iodinated SP-A to type II cells in the presence of P63 Ab were determined. Binding (4 degrees C, 1 h) of (125)I-SP-A to type II cells demonstrated both specific (calcium-dependent) and nonspecific (calcium-independent) components. Ab to P63 protein blocked the specific binding of (125)I-SP-A to type II cells and did not change the nonspecific SP-A association. A549 cells, a pneumocyte model cell line, expressed substantial levels of P63 and demonstrated specific binding of (125)I-SP-A that was inhibited by the P63 Ab. The secretagogue (cAMP)-stimulated increase in calcium-dependent binding of SP-A to type II cells was blocked by the presence of P63 Ab. Transfection of type II cells with small interfering RNA to P63 reduced P63 protein expression, attenuated P63-specific SP-A binding, and reversed the ability of SP-A to prevent surfactant secretion from the cells. Our results further substantiate the role of P63 as an SP-A receptor protein localized on the surface of lung type II cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708633      PMCID: PMC2575944          DOI: 10.1152/ajplung.90233.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  43 in total

1.  Surfactant protein A accumulating in the alveoli of patients with pulmonary alveolar proteinosis: oligomeric structure and interaction with lipids.

Authors:  A Hattori; Y Kuroki; T Katoh; H Takahashi; H Q Shen; Y Suzuki; T Akino
Journal:  Am J Respir Cell Mol Biol       Date:  1996-06       Impact factor: 6.914

2.  Human surfactant protein A with two distinct oligomeric structures which exhibit different capacities to interact with alveolar type II cells.

Authors:  A Hattori; Y Kuroki; H Sohma; Y Ogasawara; T Akino
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

3.  Lung surfactant apoprotein SP-A (26-36 kDa) binds with high affinity to isolated alveolar type II cells.

Authors:  J R Wright; J D Borchelt; S Hawgood
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  Purification of a cell-surface receptor for surfactant protein A.

Authors:  Z C Chroneos; R Abdolrasulnia; J A Whitsett; W R Rice; V L Shepherd
Journal:  J Biol Chem       Date:  1996-07-05       Impact factor: 5.157

5.  Receptor-mediated regulation of pulmonary surfactant secretion.

Authors:  D S Strayer; R Pinder; A Chander
Journal:  Exp Cell Res       Date:  1996-07-10       Impact factor: 3.905

6.  Increased surfactant internalization by rat type II cells cultured on microporous membranes.

Authors:  M R Chinoy; C Dodia; A B Fisher
Journal:  Am J Physiol       Date:  1993-03

7.  Surfactant protein A regulates uptake of pulmonary surfactant by lung type II cells on microporous membranes.

Authors:  S R Bates; C Dodia; A B Fisher
Journal:  Am J Physiol       Date:  1994-12

8.  Surfactant protein-A plays an important role in lung surfactant clearance: evidence using the surfactant protein-A gene-targeted mouse.

Authors:  Sandra R Bates; Chandra Dodia; Jian-Qin Tao; Aron B Fisher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-12-14       Impact factor: 5.464

9.  Characterization of a novel 63 kDa membrane protein. Implications for the organization of the ER-to-Golgi pathway.

Authors:  A Schweizer; M Ericsson; T Bächi; G Griffiths; H P Hauri
Journal:  J Cell Sci       Date:  1993-03       Impact factor: 5.285

10.  A reversibly palmitoylated resident protein (p63) of an ER-Golgi intermediate compartment is related to a circulatory shock resuscitation protein.

Authors:  A Schweizer; J Rohrer; P Jenö; A DeMaio; T G Buchman; H P Hauri
Journal:  J Cell Sci       Date:  1993-03       Impact factor: 5.285

View more
  11 in total

1.  Role of the PI3-kinase signaling pathway in trafficking of the surfactant protein A receptor P63 (CKAP4) on type II pneumocytes.

Authors:  Altaf S Kazi; Jian-Qin Tao; Sheldon I Feinstein; Li Zhang; Aron B Fisher; Sandra R Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-24       Impact factor: 5.464

2.  Impaired Lysosomal Integral Membrane Protein 2-dependent Peroxiredoxin 6 Delivery to Lamellar Bodies Accounts for Altered Alveolar Phospholipid Content in Adaptor Protein-3-deficient pearl Mice.

Authors:  Seunghyi Kook; Ping Wang; Lisa R Young; Michael Schwake; Paul Saftig; Xialian Weng; Ying Meng; Dante Neculai; Michael S Marks; Linda Gonzales; Michael F Beers; Susan Guttentag
Journal:  J Biol Chem       Date:  2016-02-23       Impact factor: 5.157

3.  Pathway to lamellar bodies for surfactant protein A.

Authors:  Aron B Fisher; Chandra Dodia; Peter Ruckert; Jian-Qin Tao; Sandra R Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-09       Impact factor: 5.464

4.  CKAP4 is a Dickkopf1 receptor and is involved in tumor progression.

Authors:  Hirokazu Kimura; Katsumi Fumoto; Kensaku Shojima; Satoshi Nojima; Yoshihito Osugi; Hideo Tomihara; Hidetoshi Eguchi; Yasushi Shintani; Hiroko Endo; Masahiro Inoue; Yuichiro Doki; Meinoshin Okumura; Eiichi Morii; Akira Kikuchi
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

5.  Palmitoylation of cytoskeleton associated protein 4 by DHHC2 regulates antiproliferative factor-mediated signaling.

Authors:  Sonia L Planey; Susan K Keay; Chen-Ou Zhang; David A Zacharias
Journal:  Mol Biol Cell       Date:  2009-01-14       Impact factor: 4.138

Review 6.  P63 (CKAP4) as an SP-A receptor: implications for surfactant turnover.

Authors:  Sandra R Bates
Journal:  Cell Physiol Biochem       Date:  2009-12-22

Review 7.  Pulmonary surfactant: an immunological perspective.

Authors:  Zissis C Chroneos; Zvjezdana Sever-Chroneos; Virginia L Shepherd
Journal:  Cell Physiol Biochem       Date:  2009-12-22

8.  CKAP4 inhibited growth and metastasis of hepatocellular carcinoma through regulating EGFR signaling.

Authors:  Shuang-Xi Li; Li-Juan Liu; Li-Wei Dong; Hong-Guang Shi; Yu-Fei Pan; Ye-Xiong Tan; Jian Zhang; Bo Zhang; Zhi-Wen Ding; Tian-Yi Jiang; He-Ping Hu; Hong-Yang Wang
Journal:  Tumour Biol       Date:  2014-05-18

9.  Antiproliferative factor (APF) binds specifically to sites within the cytoskeleton-associated protein 4 (CKAP4) extracellular domain.

Authors:  Burzin Chavda; Jun Ling; Thomas Majernick; Sonia Lobo Planey
Journal:  BMC Biochem       Date:  2017-09-11       Impact factor: 4.059

Review 10.  The Dickkopf1-cytoskeleton-associated protein 4 axis creates a novel signalling pathway and may represent a molecular target for cancer therapy.

Authors:  Akira Kikuchi; Katsumi Fumoto; Hirokazu Kimura
Journal:  Br J Pharmacol       Date:  2017-07-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.